FDA Panel Votes to Approve ‘Female Viagra’ With Conditions After Third Hearing

By: Gillian Mohney and Lana Zak

Article Reprint

 An expert panel for the U.S. Food and Drug Administration voted today to approve a drug that has been dubbed the “female Viagra” after two previous attempts failed to gain approval.